Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations.
Publication/Presentation Date
12-1-2023
Volume
146
Issue
6
First Page
849
Last Page
852
ISSN
1432-0533
Published In/Presented At
Roberts, H. J., Ji, S., Picca, A., Sanson, M., Garcia, M., Snuderl, M., Schüller, U., Picart, T., Ducray, F., Green, A. L., Nakano, Y., Sturm, D., Abdullaev, Z., Aldape, K., Dang, D., Kumar-Sinha, C., Wu, Y. M., Robinson, D., Vo, J. N., Chinnaiyan, A. M., … Koschmann, C. (2023). Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations. Acta neuropathologica, 146(6), 849–852. https://doi.org/10.1007/s00401-023-02640-7
Disciplines
Medicine and Health Sciences | Pediatrics
PubMedID
37851269
Department(s)
Department of Pediatrics
Document Type
Article
COinS